These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 17786164)

  • 41. Linking stress-signaling, glutathione metabolism, signaling pathways and xenobiotic transporters.
    Yadav S; Zajac E; Singhal SS; Awasthi S
    Cancer Metastasis Rev; 2007 Mar; 26(1):59-69. PubMed ID: 17260165
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2.
    Lepper ER; Nooter K; Verweij J; Acharya MR; Figg WD; Sparreboom A
    Pharmacogenomics; 2005 Mar; 6(2):115-38. PubMed ID: 15882131
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacogenetics/genomics of membrane transporters in cancer chemotherapy.
    Huang Y
    Cancer Metastasis Rev; 2007 Mar; 26(1):183-201. PubMed ID: 17323126
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ABCG2: determining its relevance in clinical drug resistance.
    Robey RW; Polgar O; Deeken J; To KW; Bates SE
    Cancer Metastasis Rev; 2007 Mar; 26(1):39-57. PubMed ID: 17323127
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Non P-glycoprotein novel proteins involved in human cancer multidrug resistance.
    Baggetto LG
    Bull Cancer; 1997 Apr; 84(4):385-90. PubMed ID: 9238162
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade.
    Kathawala RJ; Gupta P; Ashby CR; Chen ZS
    Drug Resist Updat; 2015 Jan; 18():1-17. PubMed ID: 25554624
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Importance of ABCC1 for cancer therapy and prognosis.
    Kunická T; Souček P
    Drug Metab Rev; 2014 Aug; 46(3):325-42. PubMed ID: 24670052
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cancer Drug Resistance: A Brief Overview from a Genetic Viewpoint.
    Rueff J; Rodrigues AS
    Methods Mol Biol; 2016; 1395():1-18. PubMed ID: 26910065
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multidrug Resistance Proteins (MRPs) and Cancer Therapy.
    Zhang YK; Wang YJ; Gupta P; Chen ZS
    AAPS J; 2015 Jul; 17(4):802-12. PubMed ID: 25840885
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of ABC-cassette transporters (MDR1, MRP1, BCRP) in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer.
    Kovalev AA; Tsvetaeva DA; Grudinskaja TV
    Exp Oncol; 2013 Dec; 35(4):287-90. PubMed ID: 24382439
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elacridar enhances the cytotoxic effects of sunitinib and prevents multidrug resistance in renal carcinoma cells.
    Sato H; Siddig S; Uzu M; Suzuki S; Nomura Y; Kashiba T; Gushimiyagi K; Sekine Y; Uehara T; Arano Y; Yamaura K; Ueno K
    Eur J Pharmacol; 2015 Jan; 746():258-66. PubMed ID: 25455500
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Curcumin as chemosensitizer.
    Limtrakul P
    Adv Exp Med Biol; 2007; 595():269-300. PubMed ID: 17569216
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transcriptional regulation of ABC drug transporters.
    Scotto KW
    Oncogene; 2003 Oct; 22(47):7496-511. PubMed ID: 14576854
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells.
    Szakács G; Annereau JP; Lababidi S; Shankavaram U; Arciello A; Bussey KJ; Reinhold W; Guo Y; Kruh GD; Reimers M; Weinstein JN; Gottesman MM
    Cancer Cell; 2004 Aug; 6(2):129-37. PubMed ID: 15324696
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytotoxicity of the bisphenolic honokiol from Magnolia officinalis against multiple drug-resistant tumor cells as determined by pharmacogenomics and molecular docking.
    Saeed M; Kuete V; Kadioglu O; Börtzler J; Khalid H; Greten HJ; Efferth T
    Phytomedicine; 2014 Oct; 21(12):1525-33. PubMed ID: 25442261
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacodynamic mechanisms of anti-inflammatory drugs on the chemosensitization of multidrug-resistant cancers and the pharmacogenetics effectiveness.
    Gholamian Dehkordi N; Mirzaei SA; Elahian F
    Inflammopharmacology; 2021 Feb; 29(1):49-74. PubMed ID: 33070257
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genomics and cancer drug resistance.
    Rodrigues AS; Dinis J; Gromicho M; Martins C; Laires A; Rueff J
    Curr Pharm Biotechnol; 2012 Apr; 13(5):651-73. PubMed ID: 22122479
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An outline of main factors of drug resistance influencing cancer therapy.
    Frączek N; Bronisz I; Pietryka M; Kępińska D; Strzała P; Mielnicka K; Korga A; Dudka J
    J Chemother; 2016 Dec; 28(6):457-464. PubMed ID: 27545330
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evolution of drug resistance in cancer: the emergence of unique mechanisms and novel techniques.
    Calcagno AM
    Mol Pharm; 2011 Dec; 8(6):1993. PubMed ID: 22136313
    [No Abstract]   [Full Text] [Related]  

  • 60. Mechanisms of resistance against cancer therapeutic drugs.
    Chatterjee S; Damle SG; Sharma AK
    Curr Pharm Biotechnol; 2014; 15(12):1105-12. PubMed ID: 25429651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.